Product NDC: | 0088-2100 |
Proprietary Name: | Priftin |
Non Proprietary Name: | rifapentine |
Active Ingredient(s): | 150 mg/1 & nbsp; rifapentine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0088-2100 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021024 |
Marketing Category: | NDA |
Start Marketing Date: | 20090330 |
Package NDC: | 0088-2100-03 |
Package Description: | 4 BLISTER PACK in 1 CARTON (0088-2100-03) > 8 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 0088-2100-03 |
Proprietary Name | Priftin |
Package Description | 4 BLISTER PACK in 1 CARTON (0088-2100-03) > 8 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 0088-2100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rifapentine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20090330 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | RIFAPENTINE |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Rifamycin Antimycobacterial [EPC],Rifamycins [Chemical/Ingredient] |